Skip to main content

FIGURE 1 from Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice

Publication ,  Other
Trotter, TN; Wilson, A; McBane, J; Dagotto, CE; Yang, X-Y; Wei, J-P; Lei, G; Thrash, H; Snyder, JC; Lyerly, HK; Hartman, ZC
April 9, 2024

<p>Tolerance to foreign antigens is animal model specific. <b>A</b> and <b>B,</b> Mice expressing GFP and Luc in the pituitary (GH; <i>n</i> = 5), full-body GFP, and Luc (CAG Luc-GFP; <i>n</i> = 5), in FoxP3<sup>+</sup> cells (Foxp3-GFP; <i>n</i> = 4), or wild-type (WT) C57Bl/6 (<i>n</i> = 4) were vaccinated with adenovirus (Ad) encoding GFP/Luc (2.6 × 10<sup>10</sup> vp/mouse) and anti-Luciferase (A) or anti-GFP (B) in the serum were evaluated by ELISA after 2 weeks. Only CAG Luc-GFP animals, which express both GFP and Luc, display humoral tolerance to both upon vaccination. <i>P</i> values shown are at 1:50 dilution by two-way ANOVA with Tukey multiple comparisons test. <b>C</b> and <b>D,</b> E0771 GFP-Luc cells were implanted into the MFP of female WT C57Bl/6, GH, or CAG Luc-GFP mice (<i>n</i> = 10 each) and subsequently vaccinated with Ad-GFP/Luc or Ad-LacZ as control on day 3 (<i>n</i> = 5/group each). Growth of individual tumors for the duration of the experiment (C) or average tumor volume until time of first euthanasia (D) comparing control or antigen-specific Ad demonstrate that E0771 GFP-Luc cells grow significantly larger in tolerant CAG Luc-GFP mice. <i>P</i> values shown are at day of first euthanasia by two-way ANOVA with Bonferroni multiple comparisons test. <b>E,</b> Female WT (<i>n</i> = 3) or mice expressing human HER2 under the whey acid protein (WAP) promoter (WAP HER2; <i>n</i> = 5) or MMTV Cre–driven CAG promoter (MMTV CAG HER2; <i>n</i> = 3) were vaccinated with Ad-Human Her2 and splenocytes were analyzed for anti-HER2 responses by ELISPOT after 3 weeks. WAP HER2 mice displayed reduced anti-HER2 responses compared with WT animals; however, MMTV CAG HER2 animals produced a limited anti-HER2 T-cell response compared with both WT and WAP HER2. Groups were compared by two-way ANOVA with Tukey multiple comparisons test. <b>F,</b> Doxycycline-inducible GFP animals were given doxycycline (dox)-containing chow at the indicated time points, vaccinated at 9 weeks old, and euthanized after two weeks. <b>G,</b> Serum anti-GFP responses in animals from F reveal that GFP remains highly immunogenic in mice with late (8 weeks old) versus early (4 weeks old/at birth) expression of GFP via doxycycline. <i>P</i> values shown are at 1:50 dilution by two-way ANOVA with Tukey <i>post hoc</i> analysis. All <i>P</i> values represent mean ± SEM.</p>

Duke Scholars

DOI

Publication Date

April 9, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Trotter, T. N., Wilson, A., McBane, J., Dagotto, C. E., Yang, X.-Y., Wei, J.-P., … Hartman, Z. C. (2024). FIGURE 1 from Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice. https://doi.org/10.1158/2767-9764.25569275.v1
Trotter, Timothy N., Andrea Wilson, Jason McBane, Carina E. Dagotto, Xiao-Yi Yang, Jun-Ping Wei, Gangjun Lei, et al. “FIGURE 1 from Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice,” April 9, 2024. https://doi.org/10.1158/2767-9764.25569275.v1.
Trotter TN, Wilson A, McBane J, Dagotto CE, Yang X-Y, Wei J-P, Lei G, Thrash H, Snyder JC, Lyerly HK, Hartman ZC. FIGURE 1 from Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice. 2024.

DOI

Publication Date

April 9, 2024